Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Estimation of Coagulation Factor XIII Activity Based on the Initial Plasma Fibrinogen Level in Trauma

NCT03634215 is registered in ClinicalTrials.gov with Masaryk Hospital Krajská zdravotní a.s. as lead sponsor.

NCT NCT03634215
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03634215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Estimation of Coagulation Factor XIII Activity Based on the Initial Plasma Fibrinogen Level in Trauma
Lead sponsor
Masaryk Hospital Krajská zdravotní a.s.
Phase
Observational
Overall status
Completed
Start date
September 1, 2018
Completion date
March 31, 2019
Enrollment
357 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

coagulation defect; acquired, coagulation disorder, coagulation factor deficiency, multiple trauma